Product correctly added to cart.

Preladenant

CAS: 377727-87-2 - Preladenant

Formula:C25H29N9O3

InChI:InChI=1S/C25H29N9O3/c1-35-15-16-36-19-6-4-18(5-7-19)32-11-8-31(9-12-32)10-13-33-23-20(17-27-33)24-28-22(21-3-2-14-37-21)30-34(24)25(26)29-23/h2-7,14,17H,8-13,15-16H2,1H3,(H2,26,29)

InChI key:InChIKey=DTYWJKSSUANMHD-UHFFFAOYSA-N

SMILES:N1=CC=2C3=NC(=NN3C(=NC2N1CCN4CCN(C5=CC=C(OCCOC)C=C5)CC4)N)C=6OC=CC6

  • Synonyms:
  • 2-(2-Furanyl)-7-[2-[4-[4-(2-methoxyethoxy)phenyl]-1-piperazinyl]ethyl]-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine
  • 7H-Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine, 2-(2-furanyl)-7-[2-[4-[4-(2-methoxyethoxy)phenyl]-1-piperazinyl]ethyl]-
  • Sch 420814
Sort by


See more categories

This search does not contain any category.

Found 4 products.

discount label

Preladenant

CAS:377727-87-2

Ref: AN-AG0077XI

Undefined sizeTo inquire
Estimated delivery in United States, on Wednesday 10 Apr 2024
discount label

Preladenant

CAS:377727-87-2

Ref: TM-T4290

1mg40.00 €
2mg52.00 €
5mg83.00 €
10mg122.00 €
25mg208.00 €
50mg343.00 €
100mg510.00 €
500mg1,106.00 €
Estimated delivery in United States, on Wednesday 17 Apr 2024
discount label

Preladenant

CAS:377727-87-2

Ref: 3D-FP27156

1g2,046.00 €
5mg108.00 €
25mg165.00 €
50mg216.00 €
100mg316.00 €
Estimated delivery in United States, on Tuesday 23 Apr 2024
discount label

Preladenant

CAS:377727-87-2

Ref: TR-P712600

100mg10,915.00 €
Estimated delivery in United States, on Tuesday 21 May 2024
Welcome to CymitQuimica!Please accept the use of cookies to have a better experience on our website.

Cookies are important for you, they influence your browsing experience, they help us to protect your privacy and allow us to proceed with the requests that you demand through this website. We use our own and third-party cookies to analyze our services. If you consent to its installation, click on "Accept", otherwise click on "Reject". You can also set your preferences by clicking "Settings". More information is available in our Cookies Policy.